Skip to main content
. Author manuscript; available in PMC: 2015 Jun 13.
Published in final edited form as: Mol Imaging Biol. 2008 Jun 10;10(5):271–280. doi: 10.1007/s11307-008-0151-6

Fig. 1.

Fig. 1

Graphs of total protein and albumin for each subject at the four time points of data collection. Subject 4 showed declines in both parameters. Complications of bevacizumab and irinotecan treatment explain these declines.